Kenya's virus cases rise to 11,252 as seven more die

In Summary

• This is out of 4,261 samples tested in the last 24 hours.

• Another 51 patients have been discharged, bringing the total to 3,068

Health CAS Rashid Aman during the daily briefing on coronavirus pandemic at Afya House on July 15,2020/ MERCY MUMO
Health CAS Rashid Aman during the daily briefing on coronavirus pandemic at Afya House on July 15,2020/ MERCY MUMO

Kenya on Wednesday recorded 461 Covid-19 cases, bringing the total number to 11,252.

This is out of 4,261 samples tested in the last 24 hours. Kenya's COVID-19 caseload crosses the 11,000 mark.

This now brings the case load to 11,252 and pushes the country's cumulative tests carried out so far to 225,495.

Another 51 patients have been discharged, bringing the total to 3,068

 

Health CAS Rashid Aman lauded health workers for their efforts.

However, another seven have died, bringing the number of fatalities to 209.

Of the positive cases, 432 are Kenyans and 29 are foreigners.

In terms of age, 320 are males and 141 are females, with the youngest being a one year old infant while the oldest is 86 years old.

As of distribution of the cases by counties, Nairobi leads with 248 cases, followed by Machakos 97, Kiambu 20, Kajiado 15, Migori 14, Busia 12, Nakuru 11.

Others are Laikipia and Nyeri with seven cases each, Kilifi six, Lamu and Uasin Gishu with four, Kakamega and Kisii with three, Kisumu and Makueni with two and Mombasa, Taita Taveta and Bomet have one case each.

The rising cases come as an experimental vaccine for Covid-19 by US pharmaceutical firm Moderna Inc showed it was safe and provoked an immune responses in all 45 healthy volunteers in an ongoing early-stage study, US researchers reported.

Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from Covid-19, the team reported in the New England Journal of Medicine.

No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. These were more likely to occur after the second dose and in people who got the highest dose.

 During Kenya's daily Covid-19 briefing, Health acting director general Dr Patrick Amoth said, "Something exciting is coming from America, all the 45 people given the vaccine developed an immune reaction."

Experts say a vaccine is needed to put an end to the coronavirus pandemic that has sickened millions and caused nearly 575,000 deaths worldwide.